These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10909319)

  • 41. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of ventricular arrhythmias.
    Aronow WS
    Minerva Cardioangiol; 2010 Dec; 58(6):657-76. PubMed ID: 21135807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Drug therapy of ventricular tachycardia].
    Hermida JS; Jarry G; Rey JL; Quiret JC
    Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():15-20. PubMed ID: 9749280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator].
    de Vasconcelos JT; Galvão Filho Sdos S; Barcellos CM
    Arq Bras Cardiol; 2003 Mar; 80(3):336-9. PubMed ID: 12856278
    [No Abstract]   [Full Text] [Related]  

  • 48. Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation.
    Rajawat YS; Dias D; Gerstenfeld EP; Dixit S; Shah B; Russo AM; Marchlinski FE
    Curr Cardiol Rep; 2002 Sep; 4(5):434-40. PubMed ID: 12169241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress].
    Cappato R; Kuck KH
    G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135
    [No Abstract]   [Full Text] [Related]  

  • 50. Ventricular tachycardia and sudden cardiac death.
    Reddy PC; Tandon N; Stafford PR
    J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current management of ventricular arrhythmias.
    Anderson MH
    Br J Hosp Med; 1994 Sep 7-20; 52(5):204-9. PubMed ID: 7529627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implantable cardioverter defibrillators--for whom?
    Connolly SJ
    Lancet; 1998 Aug; 352(9125):338-40. PubMed ID: 9717916
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Navigation in the mega-trials waters: reflections on the Multicenter Automatic Defibrillator Implantation Trial and the Antiarrhythmics Versus Implantable Defibrillators Study.
    Farré J
    Am J Cardiol; 1999 Mar; 83(5B):5D-7D. PubMed ID: 10089833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias.
    Krol RB; Saksena S; Prakash A
    Curr Cardiol Rep; 1999 Nov; 1(4):282-8. PubMed ID: 10980855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of left ventricular dysfunction on outcomes with the implantable defibrillator.
    Dorian P; Connolly S; Yusuf S
    Am Heart J; 1994 Apr; 127(4 Pt 2):1159-63. PubMed ID: 8160596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ventricular arrhythmias : What has been confirmed in therapy?].
    Duncker D; Bauersachs J; Veltmann C
    Internist (Berl); 2017 Dec; 58(12):1272-1280. PubMed ID: 29071387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

  • 60. [Ventricular arrhythmias].
    Waleffe A; Piérard LA
    Rev Med Liege; 2004 Apr; 59(4):190-5. PubMed ID: 15182026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.